These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6350857)

  • 1. The vascular, inflammatory, and fibrotic components in scleroderma skin.
    Fleischmajer R; Perlish JS
    Monogr Pathol; 1983; 24():40-54. PubMed ID: 6350857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electron microscopy study of pathological collagen fibril formation in systemic scleroderma].
    Ptashekas RS; Vaĭtkene DI
    Arkh Patol; 1984; 46(7):49-54. PubMed ID: 6477175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Various aspects of the pathogenesis of systemic scleroderma and the role of microcirculation in the morphogenesis of joint changes in the diseases].
    Rusakova MS
    Vopr Revm; 1982; (2):68-71. PubMed ID: 7113091
    [No Abstract]   [Full Text] [Related]  

  • 4. [New developments in the pathology, pathophysiology and therapy of systemic scleroderma].
    Asboe-Hansen G
    Hautarzt; 1980 Nov; 31(11):584-7. PubMed ID: 7451139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiology of the fibrosis in scleroderma skin.
    Fleischmajer R; Perlish JS
    Prog Clin Biol Res; 1984; 154():381-404. PubMed ID: 6382305
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vascular lesions and fibroblast metabolism in inflammatory diseases].
    Lapière CM
    Phlebologie; 1987; 40(1):21-9. PubMed ID: 3575433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progressive systemic sclerosis. A diagnostic problem].
    Posada de la Paz M; Martínez L de Letona J; Masa Vázquez C; Ruiz Galiana J; Pérez Alvarez R; Díez García F; Pérez Maestu R
    Rev Clin Esp; 1983 Sep; 170(6):237-41. PubMed ID: 6361922
    [No Abstract]   [Full Text] [Related]  

  • 8. [Physiopathology of scleroderma].
    Fleischmajer R; Perlish JS; Maquart FX; Kalis B
    Ann Dermatol Venereol; 1993; 120(2):157-66. PubMed ID: 8363310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of scleroderma. Current concepts.
    Lee EB; Anhalt GJ; Voorhees JJ; Diaz LA
    Int J Dermatol; 1984 Mar; 23(2):85-9. PubMed ID: 6698691
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis.
    Rajkumar VS; Sundberg C; Abraham DJ; Rubin K; Black CM
    Arthritis Rheum; 1999 May; 42(5):930-41. PubMed ID: 10323448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of subcutaneous tissue in systemic scleroderma.
    Fleischmajer R; Damiano V; Nedwich A
    Arch Dermatol; 1972 Jan; 105(1):59-66. PubMed ID: 5009623
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphodiesterase inhibitors in the management of autoimmune disease.
    Shenoy P; Agarwal V
    Autoimmun Rev; 2010 May; 9(7):511-5. PubMed ID: 20149898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrastructural and biochemical studies of collagen in scleroderma].
    Dabrowski J; Stachów A; Jabłońska S; Iwańska J; Walski M
    Przegl Dermatol; 1977; 64(6):665-71. PubMed ID: 609755
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tumor necrosis factor alpha in systemic scleroderma].
    Alekperov RT; Timchenko AV; Nasonov EL
    Klin Med (Mosk); 2003; 81(12):4-7. PubMed ID: 14971148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of skin scleroderma--literature review].
    Wojas-Pelc A; Lipko-Godlewska S
    Przegl Lek; 2005; 62(5):310-3. PubMed ID: 16334538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scleroderma: pathogenic factors and current management.
    Penny R
    Aust N Z J Med; 1978; 8 Suppl 1():143-8. PubMed ID: 365159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover?
    Cutolo M; Sulli A; Smith V
    Expert Rev Clin Immunol; 2011 Jul; 7(4):395-7. PubMed ID: 21790279
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis.
    Salmon-Ehr V; Serpier H; Nawrocki B; Gillery P; Clavel C; Kalis B; Birembaut P; Maquart FX
    Arch Dermatol; 1996 Jul; 132(7):802-6. PubMed ID: 8678573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferons and scleroderma-a new clue to understanding the pathogenesis of scleroderma?
    Coelho LF; de Oliveira JG; Kroon EG
    Immunol Lett; 2008 Jun; 118(2):110-5. PubMed ID: 18499269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathogenesis of scleroderma--evolving concepts.
    Sapadin AN; Esser AC; Fleischmajer R
    Mt Sinai J Med; 2001; 68(4-5):233-42. PubMed ID: 11514910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.